Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-22-000043

Chief Executive Officer acquired 142,457 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mallon Mark · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 1 in the form +142,457 368,051 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +347,777 347,777 D
Loading xslF345X03/wf-form4_164635552579023.xml…